EGLS winds up

At their final meeting, EU commissioner's life science advisors warn about US dominance

Written byAndrew Scott
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The European Group on Life Sciences (EGLS) held its final workshop and plenary meeting this week (September 28–29) in Brussels. It bowed out with a discussion on the future challenges for European life sciences research.

Former EU research commissioner Philippe Busquin set up the EGLS in 2000, bringing together 15 prominent scientists to advise him about key developments and issues in life sciences research. Its work finishes with the end of Busquin's term. The new research commissioner, Janez Potočnik, will take office on November 1, subject to approval procedures now underway.

At the final workshop, Victor de Lorenzo, EGLS president, expressed concern about American efforts to sequence microbial genomes and gain commercial rights over the results. He commented: "The ongoing conquest of the global genome at the other side of the Atlantic, not matched at all by any significant European effort, will result in the ownership of massive genetic resources ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies